Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations

ABSTRACT Introduction Lymphatic malformations (LMs) are rare vascular anomalies predominantly affecting infants, which can be debilitating or life‐threatening when complicated with intralesional bleeding or infection. Effective and safe management strategies are essential in such cases. Case present...

Full description

Bibliographic Details
Main Authors: Shixiao Dong, Li Li, Jiaosheng Xu, Zhonglong Han, Xia Zheng
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Pediatric Investigation
Subjects:
Online Access:https://doi.org/10.1002/ped4.12397
_version_ 1827813637565186048
author Shixiao Dong
Li Li
Jiaosheng Xu
Zhonglong Han
Xia Zheng
author_facet Shixiao Dong
Li Li
Jiaosheng Xu
Zhonglong Han
Xia Zheng
author_sort Shixiao Dong
collection DOAJ
description ABSTRACT Introduction Lymphatic malformations (LMs) are rare vascular anomalies predominantly affecting infants, which can be debilitating or life‐threatening when complicated with intralesional bleeding or infection. Effective and safe management strategies are essential in such cases. Case presentation We report a case series involving four Chinese neonates with life‐threatening LMs, initially treated with oral sirolimus. All patients achieved rapid relief and sustained remission, using a lower sirolimus dosage than previously recommended. Furthermore, adverse events were rarely recorded during follow‐up. Conclusion Sirolimus can be considered a promising choice for neonates with intricate and life‐threatening LMs. Initiation with a reduced sirolimus dose is advisable.
first_indexed 2024-03-11T23:33:47Z
format Article
id doaj.art-740158f604f3440fbf0d025bdad80bc3
institution Directory Open Access Journal
issn 2574-2272
language English
last_indexed 2024-03-11T23:33:47Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Pediatric Investigation
spelling doaj.art-740158f604f3440fbf0d025bdad80bc32023-09-20T05:30:03ZengWileyPediatric Investigation2574-22722023-09-017320621110.1002/ped4.12397Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformationsShixiao Dong0Li Li1Jiaosheng Xu2Zhonglong Han3Xia Zheng4Department of Neonatology, Neonatal Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Dermatology, Plastic Surgery Hospital Chinese Academy of Medical Sciences Beijing ChinaDepartment of Dermatology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Radiology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neonatology, Neonatal Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaABSTRACT Introduction Lymphatic malformations (LMs) are rare vascular anomalies predominantly affecting infants, which can be debilitating or life‐threatening when complicated with intralesional bleeding or infection. Effective and safe management strategies are essential in such cases. Case presentation We report a case series involving four Chinese neonates with life‐threatening LMs, initially treated with oral sirolimus. All patients achieved rapid relief and sustained remission, using a lower sirolimus dosage than previously recommended. Furthermore, adverse events were rarely recorded during follow‐up. Conclusion Sirolimus can be considered a promising choice for neonates with intricate and life‐threatening LMs. Initiation with a reduced sirolimus dose is advisable.https://doi.org/10.1002/ped4.12397DosageLymphatic malformationsNeonatesSirolimus
spellingShingle Shixiao Dong
Li Li
Jiaosheng Xu
Zhonglong Han
Xia Zheng
Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
Pediatric Investigation
Dosage
Lymphatic malformations
Neonates
Sirolimus
title Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
title_full Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
title_fullStr Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
title_full_unstemmed Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
title_short Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
title_sort rapid response with good toleration of sirolimus for life threatening neonatal lymphatic malformations
topic Dosage
Lymphatic malformations
Neonates
Sirolimus
url https://doi.org/10.1002/ped4.12397
work_keys_str_mv AT shixiaodong rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations
AT lili rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations
AT jiaoshengxu rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations
AT zhonglonghan rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations
AT xiazheng rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations